文献速递产科

妊娠期及产后草药产品使用:一项系统综述

Herbal Medicinal Product Use During Pregnancy and the Postnatal Period: A Systematic Review.
PubMed 文献 · Obstet Gynecol · 2019-01-01

本系统综述检索8个数据库及临床试验注册库至2018年8月,纳入74项研究、47种草药产品及1,067,071名女性,报告草药产品不良事件与草药-药物相互作用。杏仁油与早产相关(OR 2.09,95%CI 1.07-4.08),口服覆盆子叶与剖宫产相关(AOR 3.47,95%CI 1.45-8.28),大量使用甘草使早产风险增加3.07倍(95%CI 1.17-8.05)。作者结论为在获得可靠安全性证据前应劝阻妊娠期及产后使用草药产品。

要点

  • 杏仁油使用与早产相关(OR 2.09,95%CI 1.07-4.08)。
  • 口服覆盆子叶与剖宫产相关(AOR 3.47,95%CI 1.45-8.28)。
  • 大量使用甘草使早产风险增加3.07倍(95%CI 1.17-8.05)。

核心结论

  • 在获得可靠的安全性证据之前,应劝阻妊娠期和产后使用草药产品。

研究设计与样本

  • 系统综述,检索Allied and Complementary Medicine Database、Cumulative Index to Nursing and Allied Health Literature、EMBASE、Cochrane Library、MEDLINE、Scopus、Web of Science及ClinicalTrials.gov,自建库至2018年8月。
  • 数据库检索获得3,487条引文,去重并审阅标题、摘要及全文后对115篇文章进行批判性评价,排除不相关及低质量文章后纳入74篇文章进行数据提取与合成。
  • 74项纳入研究中19项以药物不良反应、先天畸形、胎儿生长受限或草药-药物相互作用为主要研究目标,包括16项队列研究、1项横断面调查和2项随机对照试验。
  • 共纳入47种草药产品和1,067,071名女性。

主要发现

  • 杏仁油使用与早产相关(OR 2.09,95%CI 1.07-4.08)。
  • 口服覆盆子叶与剖宫产相关(AOR 3.47,95%CI 1.45-8.28)。
  • 大量使用甘草使早产风险增加3.07倍(95%CI 1.17-8.05)。
  • 非洲草药mwanaphepo与母亲发病率相关(AOR 1.28,95%CI 1.09-1.50),并与新生儿死亡或发病率相关。
  • 14项研究报告无不良事件;4项研究报告草药-药物相互作用,但均未研究由此产生的不良事件。

临床怎么用

  • 作者结论认为,在获得可靠的安全性证据之前,应劝阻妊娠期和产后使用草药产品。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the incidence and nature of herbal medicinal products' adverse events and herb-drug interactions used by some pregnant and postnatal women. DATA SOURCES: The Allied and Complementary Medicine Database, the Cumulative Index to Nursing and Allied Health Literature, EMBASE, the Cochrane Library, MEDLINE, Scopus, Web of Science, and ClinicalTrials.gov were searched from inception until August 2018. METHODS OF STUDY SELECTION: Any studies reporting adverse events, herb-drug interactions or absence thereof associated with herbal medicinal products used during pregnancy or the postnatal period were included. Conference abstracts, pilot studies, and nonhuman studies were excluded. All included studies were critically appraised by two independent reviewers. TABULATION, INTEGRATION AND RESULTS: Database searches retrieved 3,487 citations. After duplicate removal and review of titles, abstracts, and full-text, 115 articles were critically appraised. After excluding irrelevant and low-quality articles, 74 articles were included for data extraction and synthesis. Adverse drug reactions, congenital malformations, fetal growth retardation or herb-drug interactions were the primary study objective reported by 19 of the 74 included studies, 16 cohort studies, one cross-sectional survey, and two randomized controlled trials. A total of 47 herbal medicinal products and 1,067,071 women were included in this review. Use of almond oil was associated with preterm birth (odds ratio 2.09, 95% CI 1.07-4.08), oral raspberry leaf was associated with cesarean delivery (adjusted odds ratio [AOR] 3.47, 95% CI 1.45-8.28); heavy licorice use was associated with early preterm birth by 3.07-fold (95% CI 1.17-8.05). African herbal medicine mwanaphepo was associated with maternal morbidity (AOR 1.28; 95% CI 1.09-1.50), and neonatal death or morbidity. Fourteen studies reported absence of adverse events. Four studies reported herb-drug interactions, but none studied adverse events arising from them. CONCLUSION: The use of herbal medicinal products during pregnancy and the postnatal period should be discouraged until robust evidence of safety is available. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42017081058.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Muñoz Balbontín Y, Stewart D, Shetty A, et al. Herbal Medicinal Product Use During Pregnancy and the Postnatal Period: A Systematic Review. Obstet Gynecol. 2019. PMID: 30969204. doi:10.1097/AOG.0000000000003217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。